ATE417629T1 - Hochvisköse embolisierende mittel - Google Patents

Hochvisköse embolisierende mittel

Info

Publication number
ATE417629T1
ATE417629T1 AT00936075T AT00936075T ATE417629T1 AT E417629 T1 ATE417629 T1 AT E417629T1 AT 00936075 T AT00936075 T AT 00936075T AT 00936075 T AT00936075 T AT 00936075T AT E417629 T1 ATE417629 T1 AT E417629T1
Authority
AT
Austria
Prior art keywords
high viscosity
embolizing agents
viscosity embolizing
agents
discolsed
Prior art date
Application number
AT00936075T
Other languages
English (en)
Inventor
Thomas Whalen
Chinh Tran
Noah Roth
Richard Greff
Original Assignee
Micro Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micro Therapeutics Inc filed Critical Micro Therapeutics Inc
Application granted granted Critical
Publication of ATE417629T1 publication Critical patent/ATE417629T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Liquid Crystal Substances (AREA)
AT00936075T 1999-05-21 2000-05-19 Hochvisköse embolisierende mittel ATE417629T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13528899P 1999-05-21 1999-05-21

Publications (1)

Publication Number Publication Date
ATE417629T1 true ATE417629T1 (de) 2009-01-15

Family

ID=22467408

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00936075T ATE417629T1 (de) 1999-05-21 2000-05-19 Hochvisköse embolisierende mittel

Country Status (9)

Country Link
US (5) US6531111B1 (de)
EP (2) EP1206287B1 (de)
JP (1) JP5148030B2 (de)
AT (1) ATE417629T1 (de)
AU (1) AU5144200A (de)
CA (1) CA2371321C (de)
DE (1) DE60041138D1 (de)
ES (1) ES2319725T3 (de)
WO (1) WO2000071170A1 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001509133A (ja) * 1996-05-31 2001-07-10 マイクロ セラピューティクス インコーポレーテッド 閉塞化血管における使用のための組成物
US6051607A (en) * 1998-07-02 2000-04-18 Micro Therapeutics, Inc. Vascular embolizing compositions comprising ethyl lactate and methods for their use
EP1051116B8 (de) * 1998-12-01 2009-06-10 Washington University Vorrichtung zur intravaskulären embolisierung
ATE417629T1 (de) * 1999-05-21 2009-01-15 Micro Therapeutics Inc Hochvisköse embolisierende mittel
AU6058000A (en) * 1999-07-12 2001-01-30 Scimed Life Systems, Inc. Liquid based vaso-occlusive compositions
AU2002305401A1 (en) * 2001-05-04 2002-11-18 Concentric Medical Hydrogel filament vaso-occlusive device
US20020193812A1 (en) * 2001-05-04 2002-12-19 Concentric Medical Hydrogel vaso-occlusive device
US20030004533A1 (en) * 2001-05-04 2003-01-02 Concentric Medical Bioactive polymer vaso-occlusive device
JP4377688B2 (ja) 2001-09-04 2009-12-02 マイクロ セラピューティクス， インコーポレイテッド 複雑な血管系での使用のための、伸展性バルーンを有する閉塞カテーテル
US20030093111A1 (en) * 2001-10-26 2003-05-15 Concentric Medical Device for vaso-occlusion and interventional therapy
JP2005514985A (ja) 2002-01-14 2005-05-26 マイクロ セラピューティクス， インコーポレイテッド 高粘度塞栓組成物を用いて動脈瘤部位を塞栓するための方法
FR2839450B1 (fr) 2002-05-07 2006-04-07 Aboville Marc D Preparation medicamenteuse notamment pour le traitement des hernies discales
US7338511B2 (en) * 2002-05-24 2008-03-04 Boston Scientific-Scimed, Inc. Solid embolic material with variable expansion
WO2004033015A1 (en) * 2002-10-10 2004-04-22 Micro Therapeutics, Inc. Wire braid-reinforced microcatheter
WO2004035093A2 (en) * 2002-10-15 2004-04-29 Micro Therapeutics, Inc. Polymeric materials for site specific delivery to the body
DE602004015574D1 (de) * 2003-02-26 2008-09-18 Micro Therapeutics Inc Emboliezusammensetzungen enthaltend pyrogenes silicium
US20050025707A1 (en) * 2003-02-27 2005-02-03 Patterson William R. Fumed silica embolic compositions
US20040228797A1 (en) * 2003-03-07 2004-11-18 Bein Richard S. Compositions for use in embolizing blood vessels comprising high levels of contrast agent
US7396540B2 (en) * 2003-04-25 2008-07-08 Medtronic Vascular, Inc. In situ blood vessel and aneurysm treatment
AU2004275878B2 (en) 2003-09-25 2011-04-14 Rutgers, The State University Inherently radiopaque polymeric products for embolotherapy
US20050090804A1 (en) * 2003-10-22 2005-04-28 Trivascular, Inc. Endoluminal prosthesis endoleak management
JP5014571B2 (ja) * 2003-12-17 2012-08-29 コーディス・ニューロバスキュラー・インコーポレイテッド 活性化可能で生体活性な移植可能の医療装置およびその使用方法
US20050255230A1 (en) * 2004-05-17 2005-11-17 Clerc Claude O Method of manufacturing a covered stent
US20100087546A1 (en) * 2005-04-20 2010-04-08 Biogenic Innovations, Llc Use of dimethyl sulfone (msm) to reduce homocysteine levels
US8480797B2 (en) * 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
WO2007033083A2 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same
EP2324838A1 (de) 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Zusammensetzungen mit Dimethyl-Sulfoxid
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
EP2027729A2 (de) 2006-06-15 2009-02-25 MicroVention, Inc. Embolisierungsvorrichtung aus einem dehnbaren polymer
US9307995B2 (en) * 2006-06-15 2016-04-12 Cook Medical Technologies Llc Methods, systems and devices for the delivery of endoluminal prostheses
EP2076533B1 (de) 2007-05-02 2014-10-08 Ambrx, Inc. Modifizierte interferon-beta-polypeptide und ihre verwendungen
US8029560B2 (en) 2007-09-12 2011-10-04 Cook Medical Technologies Llc Enhanced remodelable materials for occluding bodily vessels
BRPI0821070B1 (pt) 2007-12-21 2018-10-23 Microvention Inc dispositivo para implantação e método para a preparação de um filamento de hidrogel para implantação em um animal
CA2756573A1 (en) 2008-08-19 2010-02-25 Micro Therapeutics, Inc. Detachable tip microcatheter
US9005154B2 (en) 2008-09-26 2015-04-14 Covidien Lp Valved hemodialysis catheter
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
US8757077B2 (en) 2009-04-30 2014-06-24 Technip France Spar mooring line sharing method and system
CA2777171C (en) 2009-10-26 2017-09-19 Microvention, Inc. Embolization device constructed from expansile polymer
US9839609B2 (en) 2009-10-30 2017-12-12 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
JP5713732B2 (ja) 2011-03-08 2015-05-07 日本コヴィディエン株式会社 弁付きカテーテル
CN102139128A (zh) * 2011-03-22 2011-08-03 杭州艾力康医药科技有限公司 可显影聚乙烯醇微球/颗粒栓塞剂及其制备工艺
WO2012145431A2 (en) 2011-04-18 2012-10-26 Microvention, Inc. Embolic devices
US8936784B2 (en) 2011-10-17 2015-01-20 Poly-Med, Inc. Absorbable in situ gel-forming system, method of making and use thereof
JP5989126B2 (ja) * 2011-10-17 2016-09-07 ポリ−メド インコーポレイテッド 吸収性現場ゲル形成システム、その製造方法及びその使用
US9011884B2 (en) 2012-04-18 2015-04-21 Microvention, Inc. Embolic devices
EP2861257B1 (de) 2012-06-14 2021-12-08 Microvention, Inc. Polymere behandlungszusammensetzungen
US10124087B2 (en) 2012-06-19 2018-11-13 Covidien Lp Detachable coupling for catheter
US10143822B2 (en) 2012-07-05 2018-12-04 Covidien Lp Valved tip catheters
EP2906254B1 (de) * 2012-10-15 2020-01-08 Microvention, Inc. Polymere behandlungszusammensetzungen
WO2014093197A1 (en) 2012-12-11 2014-06-19 Covidien Lp Systems for diagnosing and/or treating medical conditions
US9861515B2 (en) * 2013-10-17 2018-01-09 Revolution Contraceptives Llc Compositions and methods relating to an occlusive polymer hydrogel
WO2015153996A1 (en) 2014-04-03 2015-10-08 Micro Vention, Inc. Embolic devices
US10226533B2 (en) 2014-04-29 2019-03-12 Microvention, Inc. Polymer filaments including pharmaceutical agents and delivering same
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
WO2016201250A1 (en) 2015-06-11 2016-12-15 Microvention, Inc. Expansile device for implantation
US20170136144A1 (en) * 2015-11-12 2017-05-18 John C. Herr Compositions and methods for vas-occlusive contraception
US10368874B2 (en) 2016-08-26 2019-08-06 Microvention, Inc. Embolic compositions
US12383421B2 (en) 2017-01-05 2025-08-12 Contraline, Inc. Contraceptive devices
EP4400166A3 (de) 2017-01-05 2025-01-22 Contraline, Inc. Verfahren zum implantieren und umkehren von stimulierend wirkenden implantaten
WO2019074965A1 (en) 2017-10-09 2019-04-18 Microvention, Inc. EMBOLIC RADIOACTIVE LIQUID
FR3083090B1 (fr) * 2018-07-02 2020-06-05 Rene Chapot Agent d’embolisation
WO2020102234A1 (en) 2018-11-13 2020-05-22 Contraline, Inc. Systems and methods for delivering biomaterials
JP7562070B2 (ja) * 2019-06-19 2024-10-07 ベクトン・ディキンソン・アンド・カンパニー 治療剤の送達のための生分解性薬物溶出塞栓粒子

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527224A (en) 1967-09-05 1970-09-08 American Cyanamid Co Method of surgically bonding tissue together
US3591676A (en) 1968-11-01 1971-07-06 Eastman Kodak Co Surgical adhesive compositions
US4079124A (en) 1976-04-21 1978-03-14 Medi-Physics, Inc. Method of preparing X-ray contrast media containing ores of hafnium, tantalum and tungsten
JPS60502087A (ja) 1983-08-31 1985-12-05 キングストン・テクノロジーズ・インコーポレーテッド 注入可能な、生理学的に受容できるポリマ−組成物
US4631188A (en) 1983-08-31 1986-12-23 S.K.Y. Polymers, Ltd. (Kingston Technologies) Injectable physiologically-acceptable polymeric composition
US4795741A (en) 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
DE69114782T2 (de) 1990-08-08 1996-04-18 Takeda Chemical Industries Ltd Intravaskulär embolisierendes Mittel mit Gehalt an einem die Angiogenesis hemmenden Stoff.
US5292782A (en) 1991-02-20 1994-03-08 Novamont S.P.A. Biodegradable polymeric compositions based on starch and thermoplastic polymers
JP3040551B2 (ja) 1991-09-05 2000-05-15 株式会社カネカメディックス 人工塞栓形成用高分子溶液
JP3203382B2 (ja) 1992-03-13 2001-08-27 国立循環器病センター総長 人工塞栓形成用高分子溶液
JP2736339B2 (ja) 1992-09-30 1998-04-02 株式会社日本感光色素研究所 動脈瘤の液体塞栓材料
US5443454A (en) 1992-12-09 1995-08-22 Terumo Kabushiki Kaisha Catheter for embolectomy
US5667767A (en) * 1995-07-27 1997-09-16 Micro Therapeutics, Inc. Compositions for use in embolizing blood vessels
ES2232711T3 (es) * 1995-07-27 2005-06-01 Micro Therapeutics, Inc. Composiciones de embolizacion.
US5580568A (en) * 1995-07-27 1996-12-03 Micro Therapeutics, Inc. Cellulose diacetate compositions for use in embolizing blood vessels
US5702361A (en) * 1996-01-31 1997-12-30 Micro Therapeutics, Inc. Method for embolizing blood vessels
US5695480A (en) 1996-07-29 1997-12-09 Micro Therapeutics, Inc. Embolizing compositions
US6015541A (en) * 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions
US6155668A (en) 1998-02-13 2000-12-05 Seiko Epson Corporation Printer, method of printing, and computer program product to actualize the printer
US6051607A (en) * 1998-07-02 2000-04-18 Micro Therapeutics, Inc. Vascular embolizing compositions comprising ethyl lactate and methods for their use
JP2003500122A (ja) * 1999-05-21 2003-01-07 マイクロ・セラピューティクス・インコーポレーテッド 中間ニードル及び供給液体間に平坦界面を形成する方法
ATE417629T1 (de) 1999-05-21 2009-01-15 Micro Therapeutics Inc Hochvisköse embolisierende mittel
JP2003502131A (ja) * 1999-05-21 2003-01-21 マイクロ・セラピューティクス・インコーポレーテッド 塞栓形成組成物を用いて脈管部位に塞栓形成する方法
WO2004035093A2 (en) * 2002-10-15 2004-04-29 Micro Therapeutics, Inc. Polymeric materials for site specific delivery to the body

Also Published As

Publication number Publication date
WO2000071170A1 (en) 2000-11-30
DE60041138D1 (de) 2009-01-29
AU5144200A (en) 2000-12-12
EP1206287A4 (de) 2004-06-30
US7507394B2 (en) 2009-03-24
US20030059372A1 (en) 2003-03-27
EP1206287A1 (de) 2002-05-22
US20030086874A1 (en) 2003-05-08
EP1206287B1 (de) 2008-12-17
ES2319725T3 (es) 2009-05-12
US20020090339A1 (en) 2002-07-11
CA2371321C (en) 2008-12-23
WO2000071170A9 (en) 2002-04-18
CA2371321A1 (en) 2000-11-30
US6962689B2 (en) 2005-11-08
US6531111B1 (en) 2003-03-11
JP5148030B2 (ja) 2013-02-20
EP1987847A1 (de) 2008-11-05
US20030099597A1 (en) 2003-05-29
JP2003500114A (ja) 2003-01-07

Similar Documents

Publication Publication Date Title
ATE417629T1 (de) Hochvisköse embolisierende mittel
ATE284715T1 (de) Embolisierende zubereitungen
DE60117043D1 (de) Behandlung von mukositis
IT1309583B1 (it) Catetere perfezionato per interventi vascolari.
ATE504308T1 (de) Antimikrobielle kationische peptide und diese enthaltende formulierungen
TR200101539T2 (tr) Serum glukoz ve trigliserid seviyelerini düşürme yöntemleri.
DE10085007T1 (de) Antiinfektionszusammensetzungen zur Behandlung von erkranktem Gewebe, wie Lippenherpes
HUP0400823A3 (en) Heterocyclic compounds for treating aging-related and diabetic vascular complications, their preparation and pharmaceutical compositions containing them
ATE285798T1 (de) Radioaktive embolisierende zusammensetzungen
WO2005063745A8 (en) Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
IL183953A0 (en) Method of reducing oxidant induced damage of a food product, a pharmaceutical, or stored blood
TR200101867T2 (tr) CCR5 modülatörleri olarak piperidinler
PE14199A1 (es) Agonistas de 5-ht1f
PH31265A (en) Aqueous solution inclusion complexes of benzo-thiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof.
ATE345775T1 (de) Zusammensetzungen zur verabreichung von arzneimittelkombinationen
IS5591A (is) Grunnmassaprótínsamsetningar til sáragræðslu
PT1109571E (pt) Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
ATE363267T1 (de) Mittel zur verbesserung der hauttextur
GB0211247D0 (en) Compositions and methods for treating or preventing convulsions or seizures
ITBO990309A0 (it) Macchina per la realizzazione di sacchetti - filtro di prodotti da inf usione .
DE60234354D1 (de) Piperazinon-verbindungen als antitumorale und krebsbekämpfende mittel
EP1545479A4 (de) Zusammensetzungen aus ezetimib und verfahren zur behandlung von mit cholesterin zusammenhängenden gutartigen und bösartigen tumoren
WO2000071716A3 (en) Vascular endothelial growth factor dimers
ID25478A (id) Agonis 5-ht1f

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1206287

Country of ref document: EP